CVS Health Co. (NYSE:CVS) Shares Acquired by Claro Advisors LLC

Claro Advisors LLC grew its position in CVS Health Co. (NYSE:CVS) by 27.1% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 12,024 shares of the pharmacy operator’s stock after acquiring an additional 2,563 shares during the quarter. Claro Advisors LLC’s holdings in CVS Health were worth $756,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the company. Livelsberger Financial Advisory purchased a new stake in shares of CVS Health during the third quarter worth approximately $31,000. Crewe Advisors LLC purchased a new stake in shares of CVS Health during the first quarter worth approximately $40,000. Reston Wealth Management LLC purchased a new stake in shares of CVS Health during the third quarter worth approximately $32,000. Kathleen S. Wright Associates Inc. purchased a new stake in shares of CVS Health during the third quarter worth approximately $33,000. Finally, First Community Trust NA raised its stake in shares of CVS Health by 116.2% during the second quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock worth $33,000 after purchasing an additional 302 shares during the last quarter. 80.66% of the stock is owned by institutional investors and hedge funds.

CVS Health Stock Down 3.4 %

CVS opened at $53.19 on Monday. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80. The firm has a market cap of $66.93 billion, a P/E ratio of 13.50, a PEG ratio of 0.92 and a beta of 0.55. CVS Health Co. has a 52 week low of $52.71 and a 52 week high of $83.25. The business’s fifty day simple moving average is $59.23 and its 200 day simple moving average is $58.60.

CVS Health (NYSE:CVS) last posted its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, beating analysts’ consensus estimates of $1.08 by $0.01. The business had revenue of $95.43 billion for the quarter, compared to analyst estimates of $92.72 billion. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The business’s revenue for the quarter was up 6.3% compared to the same quarter last year. During the same quarter last year, the company earned $2.21 earnings per share. As a group, equities research analysts anticipate that CVS Health Co. will post 5.48 EPS for the current fiscal year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, November 1st. Shareholders of record on Monday, October 21st were paid a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 5.00%. The ex-dividend date of this dividend was Monday, October 21st. CVS Health’s payout ratio is 67.51%.

Wall Street Analyst Weigh In

CVS has been the subject of several analyst reports. Royal Bank of Canada cut their price target on CVS Health from $68.00 to $58.00 and set an “outperform” rating for the company in a research note on Friday. Mizuho cut their price objective on CVS Health from $73.00 to $66.00 and set an “outperform” rating for the company in a research report on Thursday, October 24th. Truist Financial increased their price objective on CVS Health from $66.00 to $76.00 and gave the stock a “buy” rating in a research report on Friday, October 11th. Evercore ISI increased their price objective on CVS Health from $62.00 to $75.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 8th. Finally, TD Cowen upgraded CVS Health from a “hold” rating to a “buy” rating and increased their price objective for the stock from $59.00 to $85.00 in a research report on Friday, October 4th. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating and twelve have assigned a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $72.44.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.